Evidence map›Paper›PMID 24789688›Full record

ArticleInternational journal of molecular medicine2014

Fifty-four novel mutations in the NF1 gene and integrated analyses of the mutations that modulate splicing.

Weihong Xu, Xiao Yang, Xiaoxia Hu, Shibo Li

Abstract read
In one paragraph

Article in International journal of molecular medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Molecular analysis ofMolecular genetics and metabolism reports · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. [Genetic analysis and prenatal diagnosis of a sporadic family with neurofibromatosis type 1].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2019
    Article
  15. Article
  16. Identification of a NovelBioMed research international · 2019
    Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Weihong XuGenetics Laboratory, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA.
Xiao YangGenetics Laboratory, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA.
Xiaoxia HuGenetics Laboratory, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA.
Shibo LiGenetics Laboratory, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurofibromatosis type 1 (NF1) is a common autosomal dominant genetic disorder caused by mutations in the NF1 gene. One of the hallmarks of NF1 is the high mutation rate in this gene. In this study, we present 127 different NF1 mutations and 54 novel mutations detected at both the genomic DNA and mRNA level using a retrospective case series review. We found that 25.2% of these different mutations induced aberrant splicing. Of note, 40.6% of these splicing errors were caused by exonic variants. In addition, one mutation produced mosaicism in the post-transcriptional profile. However, studies investigating these splicing aberrations are limited. In order to better understand the pathogenicity of NF1 and to provide a more accurate interpretation in molecular diagnostic testing, combined computational analyses were employed to elucidate the underlying mechanisms of the variants modulating NF1 gene splicing.

Indexed as

Alternative SplicingMutationBase SequenceDNAExonsGene ExpressionHumansIntronsMolecular Sequence DataNeurofibromatosis 1Neurofibromin 1Retrospective StudiesRNA, MessengerDNANeurofibromin 1RNA, Messenger

Identifiers

PMID24789688
PMCPMC4072343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.